Evolved Peroxygenase-Aryl Alcohol Oxidase Fusions for Self-Sufficient Oxyfunctionalization Reactions

Journal Article (2020)
Author(s)

Patricia Gomez De Santos (University of the Balearic Islands)

Sofia Lazaro (University of the Balearic Islands)

Javier Viña-Gonzalez (University of the Balearic Islands)

Manh Dat Hoang (Technische Universität München, University of the Balearic Islands)

Israel Sánchez-Moreno (University of the Balearic Islands)

Anton Glieder (Graz University of Technology)

Frank Hollmann (TU Delft - Applied Sciences)

Miguel Alcalde (University of the Balearic Islands)

Research Group
BT/Biocatalysis
DOI related publication
https://doi.org/10.1021/acscatal.0c03029 Final published version
More Info
expand_more
Publication Year
2020
Language
English
Research Group
BT/Biocatalysis
Issue number
22
Volume number
10
Pages (from-to)
13524-13534
Downloads counter
337
Collections
Institutional Repository
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Fungal peroxygenases are deemed emergent biocatalysts for selective C-H bond oxyfunctionalization reactions. In this study, we have engineered a functional and stable self-sufficient chimeric peroxygenase-oxidase fusion. The bifunctional biocatalyst carried a laboratory-evolved version of the fungal peroxygenase fused to an evolved fungal aryl-alcohol oxidase that supplies H2O2 in situ. Enzyme fusion libraries with peptide linkers of different sizes and amino acid compositions were designed, while attached leader sequences favored secretion in yeast. The most promising functional enzyme fusions were characterized biochemically and further tested for the synthesis of dextrorphan, a metabolite of the antitussive drug dextromethorphan. This reaction system was optimized to control the aromatic alcohol transformation rate, and therefore the H2O2 supply, to achieve total turnover numbers of 62,000, the highest value reported for the biocatalytic synthesis of dextrorphan to date. Accordingly, our study opens an avenue for the use of peroxygenase-aryl alcohol oxidase fusions in the pharmaceutical and chemical sectors.

Files

Acscatal.0c03029.pdf
(pdf | 2.32 Mb)
- Embargo expired in 05-05-2021
License info not available